Diagnosis and Quantitation of Fibrosis, Gastroenterology, vol.134, issue.6, pp.70-81, 2008. ,
DOI : 10.1053/j.gastro.2008.03.001
Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: Time for new guidelines?, Journal of Hepatology, vol.46, issue.3, pp.528-537, 2007. ,
DOI : 10.1016/j.jhep.2006.12.002
Guidelines for the diagnosis of uncomplicated cirrhosis, Gastroent??rologie Clinique et Biologique, vol.31, issue.5, pp.504-513, 2007. ,
DOI : 10.1016/S0399-8320(07)89420-6
FibroTest-ActiTest as a non-invasive marker of liver fibrosis, Gastroent??rologie Clinique et Biologique, vol.32, issue.6, pp.22-38, 2008. ,
DOI : 10.1016/S0399-8320(08)73991-5
Sampling variability of liver fibrosis in chronic hepatitis C, Hepatology, vol.36, issue.6, pp.1449-1457, 2003. ,
DOI : 10.1016/j.hep.2003.09.022
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease, Gastroenterology, vol.128, issue.7, pp.1898-1906, 2005. ,
DOI : 10.1053/j.gastro.2005.03.084
Prospective Analysis of Discordant Results between Biochemical Markers and Biopsy in Patients with Chronic Hepatitis C, Clinical Chemistry, vol.50, issue.8, pp.1344-1355, 2004. ,
DOI : 10.1373/clinchem.2004.032227
Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update, Gastroent??rologie Clinique et Biologique, vol.32, issue.6, pp.8-21, 2008. ,
DOI : 10.1016/S0399-8320(08)73990-3
Concordance in a World without a Gold Standard: A New Non-Invasive Methodology for Improving Accuracy of Fibrosis Markers, PLoS ONE, vol.55, issue.12, p.3857, 2008. ,
DOI : 10.1371/journal.pone.0003857.s012
A prospective assessment of the interlaboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease, Comparative Hepatology, vol.2, pp.3-7, 2002. ,
Intralaboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors, Clin Chem Lab Med, vol.42, pp.323-333, 2004. ,
A reference material for traceability of aspartate aminotransferase (AST) results, Clinical Chemical Laboratory Medicine, vol.43, issue.5, pp.549-53, 2005. ,
DOI : 10.1515/CCLM.2005.095
URL : https://hal.archives-ouvertes.fr/hal-00129859
Intermethod calibration of alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) results: application to Fibrotest and Actitest scores, Clin Chem Lab Med, vol.44, pp.400-406, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00129861
BN2 (Dade Behring) and modular DP (Roche Diagnostics) analysers: application to component assays of fibrotest and Actitest, Ann Biol Clin, vol.63, pp.305-318, 2005. ,
Alpha 2 macroglobulin immunoturbidimetric assays (DakoCytomation reagents) on Roche Diagnostic analysers (Modular P, Cobas Integra) Application to FibroTest-ActiTest, Ann Biol Clin, vol.63, pp.385-95, 2005. ,
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study, The Lancet, vol.357, issue.9262, pp.1069-75, 2001. ,
DOI : 10.1016/S0140-6736(00)04258-6
Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B, Journal of Hepatology, vol.39, issue.2, pp.222-252, 2003. ,
DOI : 10.1016/S0168-8278(03)00171-5
Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease, Clinical Gastroenterology and Hepatology, vol.3, issue.2, pp.167-74, 2005. ,
DOI : 10.1016/S1542-3565(04)00625-1
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease, BMC Gastroenterology, vol.277, issue.1, p.6, 2006. ,
DOI : 10.1074/jbc.M107771200
Meta-analyses of FibroTest diagnostic value in chronic liver disease, Meta-analyses of Fibrotest diagnostic value in chronic liver disease, p.40, 2007. ,
DOI : 10.1016/j.jhep.2006.12.002
An algorithm for the grading of activity in chronic hepatitis C, Hepatology, vol.24, issue.2, pp.289-93, 1996. ,
DOI : 10.1002/hep.510240201
Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest), BMC Gastroenterology, vol.360, issue.324, p.40, 2010. ,
DOI : 10.1056/NEJMoa0810084
Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study -ANRS HC02, Antivir Ther, vol.14, pp.211-220, 2009. ,
Haptoglobin Types in British, Spanish Basque and Nigerian African Populations, Nature, vol.20, issue.4612, p.824, 1958. ,
DOI : 10.1002/ajpa.1330070405
NCSS 2007 User Guide. Number Cruncher Statistical Systems software NCSS, 2007. ,
Pitfalls of liver stiffness measurement: A 5-year prospective study of 13,369 examinations, Hepatology, vol.46, pp.828-863, 2010. ,
DOI : 10.1002/hep.23425
Inappropriately Low Glycated Hemoglobin Values and Hemolysis in HIV-Infected Patients, AIDS Research and Human Retroviruses, vol.22, issue.12, pp.1242-1249, 2006. ,
DOI : 10.1089/aid.2006.22.1242
URL : https://hal.archives-ouvertes.fr/inserm-00848103
Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: The fibrovic study ??? ANRS HC02, Journal of Hepatology, vol.48, issue.5, pp.765-73, 2008. ,
DOI : 10.1016/j.jhep.2008.01.025
Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients, Journal of Hepatology, vol.50, issue.6, pp.1074-83, 2009. ,
DOI : 10.1016/j.jhep.2009.01.022
Comparison of Elastography, Serum Marker Scores, and Histology for the Assessment of Liver Fibrosis in Hepatitis B Virus (HBV)-Infected Patients in Burkina Faso, American Journal of Tropical Medicine and Hygiene, vol.82, issue.3, pp.454-462, 2010. ,
DOI : 10.4269/ajtmh.2010.09-0088
Co-clustering of denatured hemoglobin with band 3: its role in binding of autoantibodies against band 3 to abnormal and aged erythrocytes., Proceedings of the National Academy of Sciences, vol.83, issue.16, pp.6137-6178, 1986. ,
DOI : 10.1073/pnas.83.16.6137
Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis, Clinical Biochemistry, vol.39, issue.7, pp.715-736, 2006. ,
DOI : 10.1016/j.clinbiochem.2006.04.019
Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest), Comparative Hepatology, vol.3, issue.1, p.3, 2004. ,
DOI : 10.1186/1476-5926-3-3
Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome, Blood, vol.106, issue.10, pp.153483-153492, 2005. ,
DOI : 10.1182/blood-2005-05-1980
Regulation of macrophage alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein by lipopolysaccharide and interferon-gamma., Journal of Clinical Investigation, vol.91, issue.3, pp.1219-1243, 1993. ,
DOI : 10.1172/JCI116283
Non-invasive assessment of liver fibrosis: are we ready?, The Lancet, vol.375, issue.9724, pp.1419-1439, 2010. ,
DOI : 10.1016/S0140-6736(09)62195-4